Skip to main content
Log in

In vivo monitoring of serum protein cross linking in patients with diabetes mellitus. Evidence for pharmacological modification of immunoglobulin G cross links

  • Published:
Amino Acids Aims and scope Submit manuscript

Summary

It is well known that increased cross linking of proteins due to nonenzymatic glycosylation occurs in diabetic animals and humans leading to accumulation of proteins (e.g. collagen). This in turn is strongly associated with diabetic long term complications.

We developed a noninvasive method for studying in vivo cross linking and its pharmacological inhibition by L-arginine in a blind placebo controlled study with crossing over of two treatment periods of three months each.

Glycemic control was assessed by determining blood glucose, HbA1c, fructosamine, and total glycosylated hemoglobin. The patients were randomly assigned to two treatment groups A (n = 14) and B (n = 16). 20 healthy volunteers served as controls. Treatment consisted of two daily dosages of 1 g L-arginine free base. Cross linking of a human serum protein (IgG) was assessed by SDS polyacrylamide gel electrophoresis and subsequent Western blotting.

Diabetic patients showed a statistically increased number of cross links compared to normal controls (Group A: 3.6 vs 2.0 bands, group B: 3.8 vs 2.0 bands). L-arginine led to a significant reduction of cross links in both treatment groups (Group A: 3.6 to 2.1 bands, group B: 3.8 to 2.5 bands).

The described noninvasive method for assessing in vivo cross linking requires onlyµl amounts of serum and could serve to monitor protein cross linking in patients with diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barbul A, Fichell RS, Shimadzu S, et al (1985) Intravenous hyperalimentation with high arginine levels improved wound healing and immune functions. J Surg Res 38: 328–334

    PubMed  Google Scholar 

  • Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes induced arterial wall protein cross linking. Science 232: 1629–1632

    PubMed  Google Scholar 

  • Igaki N, Sakai M, Hata H, Oimomi M, Baba S, Kato H (1990) Effects of 3-deoxyglucosone on the Maillard reaction. Clin Chem 36: 631–634

    PubMed  Google Scholar 

  • Jones AF, Jennings PE, Wakefield A, Winkles J, Lunec J, Barnett AH (1988) The fluorescence of serum proteins in diabetic patients with and without retinopathy. Diab Med 5: 547–551

    Google Scholar 

  • Kato H, Cho RK, Okitani A, Hayase F (1987) Responsibility of 3-deoxyglucosone for the glucose induced polymerization of proteins. Agric Biol Chem 51: 683–689

    Google Scholar 

  • Lämmli UK (1970) A cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–682

    PubMed  Google Scholar 

  • Lubec G, Bartosch B, Mallinger R, et al. (1990a) The effect of substance L on glucose mediated cross links of collagen in thedb/db mouse. Nephron 86: 678–694

    Google Scholar 

  • Lubec G, Bartosch B, Mallinger R, et al. (1990b) The effect of substance L on glucose mediated cross links of collagen in thekk-mouse. In: Lubec G, Rosenthal GA (eds) Amino acids. Escom, Leiden, pp 670–675

    Google Scholar 

  • Lubec G, Pollak A (1980) Reduced susceptibility of nonenzymatically glycosylated glomerular basement membranes to proteases. Renal Physiol; 3: 4–9

    PubMed  Google Scholar 

  • Lunec J (1983) Free radical mediated aggregation of IgG. Agents Actions 15: 37–38

    Google Scholar 

  • Lubec G, Vierhapper H, Bailey AJ, Damjancic P, Fasching P, Sims TJ, Kampel D, Popow C, Bartosch B (1991) Influence of L-arginine on glucose mediated collagen cross links precursors in patients with diabetes mellitus. Amino Acids 1: 35–41

    Google Scholar 

  • Monnier VM, Kohn R, Cerami A (1984) Accelerated age related browning of human collagen in diabetes mellitus. Proc NAS (USA), 81: 583–587

    Google Scholar 

  • Monnier VM, Vishwanath V, Frank KE, et al (1986) Relation between complications of type I diabetes mellitus and collagen linked fluorescence. N Engl J Med 314: 402–408

    Google Scholar 

  • Oimomi M, Hata F, Igaki N, Nakamichi T, Baba S, Kato H (1989) Purification of alphaketoaldehyde dehydrogenase from human liver and its possible significance in the control of glycation. Experientia 45: 463–466

    PubMed  Google Scholar 

  • SAS User's guide: Statistics (1985) Version 5 th edn. SAS Institute, Cary, NC

    Google Scholar 

  • Schnider GL, Kohn RR (1981) Effects of age and diabetes mellitus on the solubility and nonenzymatic glycosylation of human skin collagen. J Clin Invest 67: 1630–1635

    PubMed  Google Scholar 

  • Vlassara H, Brownlee M, Cerami A (1984) Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation end products. J Exp Med 160: 197–207

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lubec, B., Weninger, M., Popow, C. et al. In vivo monitoring of serum protein cross linking in patients with diabetes mellitus. Evidence for pharmacological modification of immunoglobulin G cross links. Amino Acids 4, 111–119 (1993). https://doi.org/10.1007/BF00805806

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00805806

Keywords

Navigation